lipoxin a4 has been researched along with Diabetic Retinopathy in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Angayarkanni, N; Arif Mulla, M; Das, UN; Jithu, M; Kaviarasan, K; Sharma, T; Sivasankar, S | 1 |
| Das, UN | 3 |
1 review(s) available for lipoxin a4 and Diabetic Retinopathy
| Article | Year |
|---|---|
Lipoxins, resolvins, and protectins in the prevention and treatment of diabetic macular edema and retinopathy.
Topics: Antibodies, Monoclonal; Cytokines; Diabetic Retinopathy; Fatty Acids, Omega-3; Fatty Acids, Unsaturated; Humans; Inflammation Mediators; Interleukin-6; Lipoxins; Macular Edema; Neovascularization, Pathologic; Tumor Necrosis Factor-alpha; Vascular Endothelial Growth Factor A | 2013 |
3 other study(ies) available for lipoxin a4 and Diabetic Retinopathy
| Article | Year |
|---|---|
Low blood and vitreal BDNF, LXA4 and altered Th1/Th2 cytokine balance are potential risk factors for diabetic retinopathy.
Topics: Adult; Aged; Brain-Derived Neurotrophic Factor; Case-Control Studies; Cell Line; Cytokines; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Female; Humans; In Vitro Techniques; Lipopolysaccharides; Lipoxins; Male; Middle Aged; Prospective Studies; Retina; Risk Factors; Th1-Th2 Balance; Vascular Endothelial Growth Factor A | 2015 |
Is lipoxins A4 a better alternative to anti-TNF-alpha antibody to prevent and treat diabetic macular edema and retinopathy?
Topics: Antibodies; Diabetic Retinopathy; Fatty Acids, Unsaturated; Humans; Lipoxins; Macular Edema; Tumor Necrosis Factor-alpha | 2010 |
Is lipoxins A₄ a better alternative to anti-VEGF and anti-TNF-α antibody to prevent and treat age-related macular degeneration, diabetic macular edema and retinopathy?
Topics: Antibodies; Diabetic Retinopathy; Humans; Lipoxins; Macular Degeneration; Macular Edema | 2012 |